Colin Goddard joined Coferon as part-time Executive Chairman in 2011 and assumed the Chairman and CEO roles following the Series B financing in July 2012.From October 1998, until its $4 billion acquisition by Astellas Pharmaceuticals, Inc. in June of 2010, Dr. Goddard was CEO of OSI Pharmaceuticals, Inc., a company he joined as a scientist in 1989.
Reserach work